Literature DB >> 18250139

Posterior reversible encephalopathy syndrome during systemic lupus erythematosus: four new cases and review of the literature.

G Leroux1, J Sellam, N Costedoat-Chalumeau, D Le Thi Huong, A Combes, N Tieulié, J Haroche, Z Amoura, A Nieszkowska, J Chastre, D Dormont, J-C Piette.   

Abstract

Posterior reversible encephalopathy syndrome (PRES) associates various neurological manifestations (headaches, seizures, altered mental status, cortical blindness, focal neurological deficits, vomiting) and transient changes on neuroimaging consistent with cerebral edema. Posterior reversible encephalopathy syndrome mainly occurs in the setting of hypertension, eclampsia, renal failure and/or use of immunosuppressive drugs. We report four cases of PRES complicating systemic lupus erythematosus (SLE). In all our cases, renal involvement and hypertension were present. Neurological symptoms were typical. Magnetic resonance imaging showed posterior cerebral edema and in one case hemorrhagic complication. With symptomatic treatment and immunosuppressor withdrawal when they were previously used, symptoms fully resolved within 15 days in all cases, but one who had only partial regression related to cerebral hemorrhage. Including our cases, we reviewed a total of 46 patients with SLE and PRES. Their clinical and radiological presentation was not specific. The peculiar role of SLE itself in the occurrence of PRES was not clear, since hypertension (95%), renal involvement (91%), recent onset of immunosuppressive drugs (54%) and/or recent treatment with high intravenous dose of steroids (43%) were often present. The hypertension and other worsening factors should be treated. Finally, the evolution of this clinical and radiological spectacular syndrome is generally rapidly favorable.

Entities:  

Mesh:

Year:  2008        PMID: 18250139     DOI: 10.1177/0961203307085405

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  21 in total

1.  Cerebral angioedema associated with enalapril.

Authors:  Eric Decloedt; Rob Freercks; Gary Maartens
Journal:  Br J Clin Pharmacol       Date:  2009-08       Impact factor: 4.335

2.  Intra-Arterial Verapamil Treatment in Oral Therapy-Refractory Reversible Cerebral Vasoconstriction Syndrome.

Authors:  J M Ospel; C H Wright; R Jung; L L M Vidal; S Manjila; G Singh; D V Heck; A Ray; K A Blackham
Journal:  AJNR Am J Neuroradiol       Date:  2019-12-26       Impact factor: 3.825

Review 3.  Imaging spectrum of immunomodulating, chemotherapeutic and radiation therapy-related intracranial effects.

Authors:  Christie M Lincoln; Peter Fata; Susan Sotardi; Michael Pohlen; Tomas Uribe; Jacqueline A Bello
Journal:  Br J Radiol       Date:  2017-11-03       Impact factor: 3.039

4.  A Rare Presentation of Lupus Nephritis Flare up with Posterior Reversible Leucoencephalopathy.

Authors:  S Hima Mani; S M Shivaprasad; L Umesh
Journal:  J Clin Diagn Res       Date:  2016-01-01

Review 5.  The multifactorial origin of posterior reversible encephalopathy syndrome in cyclophosphamide-treated lupus patients.

Authors:  Tatjana Zekić; Mirjana Stanić Benić; Ronald Antulov; Igor Antončić; Srđan Novak
Journal:  Rheumatol Int       Date:  2017-10-17       Impact factor: 2.631

6.  Hypertensive brainstem encephalopathy: a diagnosis often overlooked.

Authors:  Yin Yin Tan; Kenny Tan
Journal:  Clin Med (Lond)       Date:  2019-11       Impact factor: 2.659

7.  Children with posterior reversible encephalopathy syndrome associated with atypical diffusion-weighted imaging and apparent diffusion coefficient.

Authors:  Kenji Ishikura; Yuko Hamasaki; Tomoyuki Sakai; Hiroshi Hataya; Tomohide Goto; Sahoko Miyama; Tatsuo Kono; Masataka Honda
Journal:  Clin Exp Nephrol       Date:  2010-12-10       Impact factor: 2.801

8.  Treatment of Posterior Reversible Encephalopathy Syndrome that Occurred in a Patient with Systemic Lupus Erythematosus by Plasmapheresis.

Authors:  Zehra İpek Arslan; Canan Kamile Turna; Çiğdem Yasemin Özerdem; Sara Yavuz; Nur Baykara; Mine Solak
Journal:  Turk J Anaesthesiol Reanim       Date:  2015-03-03

9.  Posterior Reversible Encephalopathy Syndrome and Anti-Angiogenic Agents: A Case Report.

Authors:  Filipe Manuel Dos Reis Simões da Silva; Peter Mike Burgos Pêgo; Maria Cristina Henriques Vendrell; Maria João de Azevedo Batalha Ferreira Dos Santos Farias; Ângela Cátia Ribeiro Timóteo; Maria Cristina Martins da Costa; Isabel Maria Monteiro Barbosa Moreira Cravo; Fernando Manuel Ribeiro Gomes
Journal:  Neuroophthalmology       Date:  2011-01-16

10.  Posterior reversible encephalopathy syndrome associated with the use of chemotherapeutic agents: a rare complication after treatment with vinorelbine.

Authors:  Ines Gil; Filipa Serrazina; Miguel Pinto; Miguel Viana-Baptista
Journal:  BMJ Case Rep       Date:  2020-02-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.